HYDROQUINONE

HYDROQUINONE was reported 592 times

HYDROQUINONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GEMELLA BACTERAEMIA 1 0.5000
1 OCHRONOSIS 11 0.1549
2 PSEUDOFOLLICULITIS BARBAE 3 0.1250
3 SPINAL CORD INJURY CAUDA EQUINA 1 0.0625
4 AXILLARY WEB SYNDROME 1 0.0476
5 PHARYNGEAL LEUKOPLAKIA 1 0.0370
6 PLEURAL MASS 2 0.0328
7 FOLLICULAR MUCINOSIS 1 0.0303
8 ANAL INJURY 5 0.0289
9 NAEVOID MELANOMA 1 0.0244
10 SKIN SQUAMOUS CELL CARCINOMA METASTATIC 2 0.0211
11 INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION 1 0.0208
12 TYPICAL AURA WITHOUT HEADACHE 2 0.0204
13 SECONDARY SYPHILIS 2 0.0202
14 NIGHT CRAMPS 1 0.0196
15 POIKILODERMA 2 0.0185
16 POLYGLANDULAR DISORDER 1 0.0147
17 OBSESSIVE RUMINATION 1 0.0143
18 INFECTIVE KERATITIS 1 0.0141
19 AUTOPHONY 1 0.0133
20 RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE 1 0.0118
21 METASTASES TO THYROID 1 0.0109
22 DEAFNESS PERMANENT 2 0.0102
23 MEDICAL DEVICE SITE INJURY 1 0.0101
24 MANUFACTURING PRODUCTION ISSUE 1 0.0096
25 NEOPLASM SKIN 14 0.0090
26 POST INFLAMMATORY PIGMENTATION CHANGE 4 0.0088
27 TUMOUR ULCERATION 2 0.0084
28 SPINAL HAEMATOMA 1 0.0083
29 BLEPHAROPLASTY 1 0.0082
30 SQUAMOUS CELL CARCINOMA OF SKIN 44 0.0073
31 MYOCARDIAL STRAIN 1 0.0072
32 PREMATURE AGEING 2 0.0068
33 CHLOASMA 3 0.0065
34 APPLICATION SITE WOUND 1 0.0061
35 AEROPHAGIA 1 0.0057
36 ABDOMINAL HERNIA REPAIR 1 0.0054
37 SPINAL CORD OPERATION 1 0.0052
38 SICCA SYNDROME 1 0.0052
39 MEDICAL DIET 1 0.0051
40 CHRONIC HEPATITIS C 2 0.0051
41 THYROID ADENOMA 1 0.0050
42 PENILE BLISTER 1 0.0047
43 PRODUCT ADVERTISING ISSUE 1 0.0047
44 LIPASE ABNORMAL 1 0.0045
45 PATIENT DISSATISFACTION WITH DEVICE 1 0.0040
46 GINGIVAL EROSION 1 0.0039
47 SKIN ATROPHY 22 0.0038
48 BONE FRAGMENTATION 2 0.0036
49 INCARCERATED HERNIA 1 0.0032
50 PLASTIC SURGERY 1 0.0031
51 SEPTIC ARTHRITIS STAPHYLOCOCCAL 1 0.0029
52 PRODUCT COMPOUNDING QUALITY ISSUE 1 0.0027
53 KERATOCONJUNCTIVITIS SICCA 1 0.0027
54 EXPOSURE TO COMMUNICABLE DISEASE 2 0.0027
55 CAROTID BRUIT 1 0.0026
56 LIPOEDEMA 1 0.0025
57 VISUAL BRIGHTNESS 1 0.0025
58 SKIN CHAPPED 1 0.0025
59 CEREBRAL ARTERY EMBOLISM 3 0.0025
60 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
61 HAEMANGIOMA OF SKIN 1 0.0023
62 GALLBLADDER CHOLESTEROLOSIS 1 0.0022
63 PULMONARY VASCULAR DISORDER 1 0.0021
64 TYPE V HYPERLIPIDAEMIA 1 0.0021
65 APPLICATION SITE ACNE 1 0.0020
66 PYODERMA 1 0.0020
67 SCIATIC NERVE NEUROPATHY 1 0.0019
68 FRACTURE PAIN 1 0.0019
69 GENITAL DISCOMFORT 1 0.0018
70 EYE INFECTION BACTERIAL 1 0.0018
71 TRICHORRHEXIS 5 0.0018
72 ANAL HAEMORRHAGE 5 0.0018
73 PROTRUSION TONGUE 1 0.0017
74 NASAL MUCOSAL DISORDER 1 0.0017
75 GINGIVAL HYPERPLASIA 1 0.0017
76 SPONDYLOARTHROPATHY 1 0.0017
77 FAT NECROSIS 1 0.0016
78 SACRAL PAIN 1 0.0016
79 NEURODEGENERATIVE DISORDER 1 0.0016
80 CHALAZION 1 0.0016
81 SILENT MYOCARDIAL INFARCTION 1 0.0015
82 ORAL MUCOSAL DISCOLOURATION 1 0.0015
83 CATARACT NUCLEAR 1 0.0015
84 STASIS DERMATITIS 1 0.0015
85 HAND DERMATITIS 1 0.0014
86 OPHTHALMIC MIGRAINE 1 0.0014
87 CUSHING'S SYNDROME 1 0.0014
88 FACIAL DISCOMFORT 1 0.0014
89 PRODUCT DESIGN ISSUE 1 0.0014
90 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
91 CHOLANGITIS ACUTE 1 0.0013
92 DIAPHRAGMATIC DISORDER 1 0.0013
93 TOE OPERATION 1 0.0013
94 TINEA PEDIS 2 0.0013
95 DEPERSONALISATION 1 0.0012
96 LOWER RESPIRATORY TRACT CONGESTION 2 0.0012
97 LIP PRURITUS 1 0.0012
98 ADENOMA BENIGN 1 0.0012
99 FIXED ERUPTION 2 0.0012
100 GENITAL BURNING SENSATION 1 0.0012
101 ENDOCRINE OPHTHALMOPATHY 1 0.0012
102 CEREBELLAR ATROPHY 1 0.0011
103 BLOOD ALBUMIN INCREASED 1 0.0011
104 SKIN WEEPING 4 0.0011
105 APPLICATION SITE DISCOMFORT 2 0.0011
106 TYPE IV HYPERSENSITIVITY REACTION 3 0.0011
107 PRURIGO 1 0.0011
108 IMPATIENCE 2 0.0011
109 APPLICATION SITE BRUISE 1 0.0010
110 GALLBLADDER INJURY 2 0.0010
111 LYMPHADENECTOMY 1 0.0010
112 DEVICE RELATED THROMBOSIS 1 0.0010
113 PIGMENTATION DISORDER 6 0.0010
114 NASAL INFLAMMATION 1 0.0009
115 SLEEP DEFICIT 2 0.0009
116 BONE DEMINERALISATION 1 0.0009
117 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
118 PRODUCT SELECTION ERROR 1 0.0009
119 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
120 DRUG EFFECT VARIABLE 1 0.0009
121 LICHENOID KERATOSIS 2 0.0009
122 CHEMICAL BURN 1 0.0009
123 AORTIC THROMBOSIS 1 0.0009
124 SURGICAL FAILURE 1 0.0009
125 BLADDER OPERATION 1 0.0009
126 EMBOLISM ARTERIAL 1 0.0008
127 PHARYNGEAL INFLAMMATION 1 0.0008
128 PENILE SWELLING 1 0.0008
129 APPLICATION SITE SCAR 1 0.0008
130 LIP DISCOLOURATION 1 0.0008
131 FRACTURED COCCYX 1 0.0008
132 PROTEIN TOTAL ABNORMAL 1 0.0008
133 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
134 TUMOUR PAIN 1 0.0008
135 RADICULOPATHY 2 0.0008
136 APPLICATION SITE DISCOLOURATION 3 0.0007
137 CLUSTER HEADACHE 1 0.0007
138 APPLICATION SITE EXFOLIATION 3 0.0007
139 APPLICATION SITE INFLAMMATION 1 0.0007
140 PERIODONTAL DISEASE 1 0.0007
141 MAST CELL ACTIVATION SYNDROME 1 0.0007
142 CONNECTIVE TISSUE DISORDER 1 0.0007
143 SKIN HYPERPIGMENTATION 6 0.0007
144 SEBORRHOEIC KERATOSIS 1 0.0007
145 DARK CIRCLES UNDER EYES 1 0.0007
146 GENERALISED ANXIETY DISORDER 1 0.0007
147 SKIN STRIAE 1 0.0007
148 REBOUND ACID HYPERSECRETION 2 0.0007
149 MOUTH INJURY 1 0.0007
150 KERATITIS 2 0.0007
151 HEAT STROKE 1 0.0007
152 RUBBER SENSITIVITY 1 0.0007
153 PNEUMONIA PSEUDOMONAL 1 0.0007
154 DIASTOLIC DYSFUNCTION 2 0.0006
155 NEPHROGENIC ANAEMIA 3 0.0006
156 ORAL MUCOSAL ERYTHEMA 1 0.0006
157 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
158 INTESTINAL ULCER 1 0.0006
159 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
160 HYPOVENTILATION 2 0.0006
161 SPINAL CORD DISORDER 1 0.0006
162 PAPILLOMA VIRAL INFECTION 1 0.0006
163 BLOOD CALCIUM ABNORMAL 1 0.0006
164 MITRAL VALVE PROLAPSE 1 0.0006
165 SPINAL DEFORMITY 1 0.0006
166 TYMPANIC MEMBRANE PERFORATION 1 0.0006
167 NEOPLASM RECURRENCE 2 0.0006
168 EXPOSURE TO SARS-COV-2 1 0.0006
169 BLADDER NEOPLASM 1 0.0006
170 ACUTE SINUSITIS 1 0.0006
171 INCORRECT STORAGE OF DRUG 1 0.0006
172 KIDNEY FIBROSIS 1 0.0006
173 VASCULAR PSEUDOANEURYSM 1 0.0006
174 ROTATOR CUFF REPAIR 1 0.0006
175 SKIN HYPOPIGMENTATION 1 0.0006
176 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
177 APPLICATION SITE PAIN 12 0.0005
178 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
179 RADIOTHERAPY 1 0.0005
180 ARTERIAL THROMBOSIS 1 0.0005
181 CONVERSION DISORDER 1 0.0005
182 OCULAR HYPERTENSION 1 0.0005
183 NASAL SEPTUM DEVIATION 1 0.0005
184 VOCAL CORD DISORDER 1 0.0005
185 SKIN PAPILLOMA 2 0.0005
186 RENAL MASS 1 0.0005
187 BLEPHAROSPASM 3 0.0005
188 DILATATION VENTRICULAR 1 0.0005
189 DEVICE MATERIAL ISSUE 1 0.0005
190 URINARY BLADDER HAEMORRHAGE 1 0.0005
191 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
192 ANAEMIA MACROCYTIC 1 0.0005
193 INTERVERTEBRAL DISC DISORDER 2 0.0005
194 MEDICAL DEVICE PAIN 1 0.0005
195 MUSCLE STRAIN 4 0.0005
196 PERIODONTITIS 1 0.0005
197 OCULAR ICTERUS 2 0.0005
198 CORNEAL DISORDER 1 0.0005
199 PNEUMOCYSTIS JIROVECI PNEUMONIA 1 0.0004
200 HAIR TEXTURE ABNORMAL 6 0.0004
201 CHOLECYSTITIS CHRONIC 3 0.0004
202 PERIARTHRITIS 1 0.0004
203 DERMATITIS CONTACT 5 0.0004
204 BREAKTHROUGH PAIN 1 0.0004
205 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
206 LICHEN PLANUS 1 0.0004
207 ROSACEA 2 0.0004
208 ORAL SURGERY 1 0.0004
209 VITILIGO 1 0.0004
210 SKIN TIGHTNESS 2 0.0004
211 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1 0.0004
212 SINUS OPERATION 1 0.0004
213 SLOW SPEECH 1 0.0004
214 APPLICATION SITE BURN 2 0.0004
215 CARTILAGE INJURY 1 0.0004
216 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
217 PLATELET DISORDER 1 0.0004
218 ECONOMIC PROBLEM 6 0.0004
219 AORTIC ARTERIOSCLEROSIS 1 0.0004
220 MUSCULOSKELETAL CHEST PAIN 6 0.0004
221 TRISMUS 2 0.0004
222 PERSONALITY DISORDER 1 0.0004
223 TOOTH INFECTION 5 0.0004
224 NASAL DISORDER 1 0.0004
225 ALCOHOL ABUSE 1 0.0004
226 GINGIVITIS 2 0.0004
227 SHOCK HAEMORRHAGIC 3 0.0004
228 SKIN WRINKLING 1 0.0004
229 CLUMSINESS 1 0.0004
230 RHINALGIA 1 0.0004
231 APPLICATION SITE RASH 5 0.0004
232 RED BLOOD CELL COUNT INCREASED 1 0.0004
233 HYPERKERATOSIS 2 0.0004
234 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
235 FOOT DEFORMITY 4 0.0004
236 CHOLECYSTITIS INFECTIVE 1 0.0004
237 PERIORBITAL SWELLING 2 0.0004
238 TUMOUR HAEMORRHAGE 1 0.0004
239 IMPAIRED QUALITY OF LIFE 5 0.0003
240 HERPES VIRUS INFECTION 2 0.0003
241 FIBULA FRACTURE 1 0.0003
242 VITAMIN B12 DECREASED 1 0.0003
243 MOUTH SWELLING 2 0.0003
244 METASTASES TO LUNG 4 0.0003
245 THORACIC VERTEBRAL FRACTURE 1 0.0003
246 THYROIDITIS 1 0.0003
247 ACNE CYSTIC 1 0.0003
248 NOCTURIA 4 0.0003
249 CHRONIC KIDNEY DISEASE 25 0.0003
250 END STAGE RENAL DISEASE 6 0.0003
251 IRITIS 1 0.0003
252 HIDRADENITIS 3 0.0003
253 INGUINAL HERNIA 2 0.0003
254 MEDICAL DEVICE DISCOMFORT 1 0.0003
255 INTRACARDIAC THROMBUS 1 0.0003
256 LARYNGEAL OEDEMA 2 0.0003
257 THERAPY PARTIAL RESPONDER 5 0.0003
258 BLOOD CREATININE DECREASED 1 0.0003
259 NASAL DRYNESS 2 0.0003
260 IRIDOCYCLITIS 1 0.0003
261 LOOSE TOOTH 1 0.0003
262 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
263 VITAMIN D DEFICIENCY 3 0.0003
264 POSTURE ABNORMAL 1 0.0003
265 ANHEDONIA 8 0.0003
266 LIGAMENT SPRAIN 3 0.0003
267 PRODUCT FORMULATION ISSUE 2 0.0003
268 SKIN INJURY 1 0.0003
269 OVARIAN CYST 3 0.0003
270 NEPHRITIS 1 0.0003
271 POST-TRAUMATIC STRESS DISORDER 2 0.0003
272 PLANTAR FASCIITIS 1 0.0003
273 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
274 APPLICATION SITE DRYNESS 1 0.0003
275 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
276 ECCHYMOSIS 2 0.0003
277 LEFT VENTRICULAR FAILURE 1 0.0003
278 LYMPHOEDEMA 2 0.0003
279 TACHYPHRENIA 1 0.0003
280 EAR PRURITUS 1 0.0003
281 ERYTHEMA NODOSUM 1 0.0003
282 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
283 INCORRECT DRUG ADMINISTRATION DURATION 8 0.0003
284 SKIN DISCOLOURATION 13 0.0003
285 SPONDYLITIS 1 0.0003
286 DEVICE KINK 1 0.0003
287 MAJOR DEPRESSION 2 0.0003
288 UTERINE LEIOMYOMA 2 0.0003
289 FOOD INTOLERANCE 1 0.0003
290 TENDON INJURY 1 0.0003
291 AUTOIMMUNE THYROIDITIS 1 0.0003
292 PARANASAL SINUS DISCOMFORT 1 0.0003
293 OSTEOPENIA 4 0.0003
294 FACE INJURY 1 0.0003
295 TONGUE OEDEMA 1 0.0003
296 PARANASAL SINUS HYPERSECRETION 1 0.0003
297 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
298 GINGIVAL DISORDER 1 0.0003
299 ORAL HERPES 5 0.0003
300 CERVIX CARCINOMA 1 0.0003
301 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
302 SKIN ODOUR ABNORMAL 1 0.0003
303 TRICUSPID VALVE INCOMPETENCE 2 0.0003
304 BLEPHARITIS 1 0.0002
305 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
306 RHINITIS 2 0.0002
307 STENT PLACEMENT 2 0.0002
308 SPINAL FUSION SURGERY 1 0.0002
309 POST PROCEDURAL INFECTION 2 0.0002
310 RECURRENT CANCER 1 0.0002
311 CARDIOMEGALY 3 0.0002
312 METASTASES TO BONE 4 0.0002
313 ARTHRITIS BACTERIAL 1 0.0002
314 INJECTION SITE EXTRAVASATION 3 0.0002
315 AORTIC DISSECTION 1 0.0002
316 CONGESTIVE CARDIOMYOPATHY 1 0.0002
317 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
318 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
319 AORTIC VALVE INCOMPETENCE 1 0.0002
320 CARDIAC MURMUR 2 0.0002
321 HORDEOLUM 1 0.0002
322 TOOTH INJURY 1 0.0002
323 DIVERTICULUM INTESTINAL 1 0.0002
324 TONGUE DISCOLOURATION 1 0.0002
325 BLOOD CALCIUM INCREASED 2 0.0002
326 ONYCHOMYCOSIS 1 0.0002
327 INTENTIONAL DEVICE MISUSE 1 0.0002
328 DYSMENORRHOEA 3 0.0002
329 PHYSICAL DISABILITY 1 0.0002
330 FOREIGN BODY IN REPRODUCTIVE TRACT 2 0.0002
331 IRON DEFICIENCY 1 0.0002
332 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
333 HAEMOGLOBIN INCREASED 1 0.0002
334 INJECTION SITE PAPULE 1 0.0002
335 PERIPHERAL COLDNESS 3 0.0002
336 ISCHAEMIA 1 0.0002
337 EYE OPERATION 1 0.0002
338 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
339 LOCALISED OEDEMA 1 0.0002
340 CONJUNCTIVITIS 4 0.0002
341 RENAL FUNCTION TEST ABNORMAL 1 0.0002
342 FEELING OF DESPAIR 1 0.0002
343 NEPHROPATHY 2 0.0002
344 CARPAL TUNNEL SYNDROME 3 0.0002
345 UMBILICAL HERNIA 1 0.0002
346 PREGNANCY WITH IMPLANT CONTRACEPTIVE 1 0.0002
347 VAGINAL INFECTION 1 0.0002
348 SQUAMOUS CELL CARCINOMA 2 0.0002
349 SKIN ABRASION 1 0.0002
350 SPINAL DISORDER 2 0.0002
351 FOOT FRACTURE 4 0.0002
352 SPUTUM DISCOLOURED 2 0.0002
353 PULSE ABSENT 1 0.0002
354 ENDOMETRIOSIS 1 0.0002
355 LIMB OPERATION 1 0.0002
356 ATELECTASIS 2 0.0002
357 FIBROMYALGIA 5 0.0002
358 NEURALGIA 5 0.0002
359 RENAL TUBULAR NECROSIS 2 0.0002
360 PANCREATIC DISORDER 1 0.0002
361 INJECTION SITE INFLAMMATION 1 0.0002
362 APPLICATION SITE SWELLING 1 0.0002
363 PROTEIN URINE PRESENT 1 0.0002
364 FLUID INTAKE REDUCED 1 0.0002
365 BONE LOSS 3 0.0002
366 DRUG TOLERANCE 1 0.0002
367 TASTE DISORDER 4 0.0002
368 PATHOLOGICAL FRACTURE 1 0.0002
369 FEMORAL NECK FRACTURE 1 0.0002
370 INITIAL INSOMNIA 2 0.0002
371 EAR DISCOMFORT 2 0.0002
372 PRODUCT COLOUR ISSUE 1 0.0002
373 INCREASED UPPER AIRWAY SECRETION 1 0.0002
374 HELICOBACTER INFECTION 2 0.0002
375 BONE DENSITY DECREASED 6 0.0002
376 APPLICATION SITE ERYTHEMA 5 0.0002
377 BLOOD LACTIC ACID INCREASED 1 0.0002
378 POLYARTHRITIS 1 0.0002
379 SCRATCH 2 0.0002
380 INCONTINENCE 2 0.0002
381 ANAL FISTULA 1 0.0002
382 COMPRESSION FRACTURE 1 0.0002
383 ANAL FISSURE 1 0.0002
384 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
385 ANAL ABSCESS 1 0.0002
386 DECREASED ACTIVITY 2 0.0002
387 ACNE 14 0.0002
388 SKIN LACERATION 2 0.0002
389 PROSTATIC DISORDER 1 0.0002
390 RASH PAPULAR 4 0.0002
391 PRODUCT LEAKAGE 1 0.0002
392 CHOLECYSTITIS ACUTE 1 0.0002
393 CARDIAC VALVE DISEASE 1 0.0002
394 EXERCISE TOLERANCE DECREASED 1 0.0002
395 ECZEMA 9 0.0002
396 LOCAL SWELLING 3 0.0002
397 SKIN WARM 1 0.0002
398 HYPERTRIGLYCERIDAEMIA 1 0.0002
399 SPINAL PAIN 2 0.0002
400 DEEP VEIN THROMBOSIS 11 0.0002
401 GALLBLADDER DISORDER 3 0.0002
402 CHOLECYSTITIS 2 0.0002
403 GASTROENTERITIS VIRAL 3 0.0002
404 TYPE 1 DIABETES MELLITUS 1 0.0002
405 DERMATITIS ACNEIFORM 1 0.0002
406 CEREBRAL INFARCTION 4 0.0002
407 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
408 DRUG DIVERSION 1 0.0002
409 SCOLIOSIS 1 0.0002
410 EYE SWELLING 6 0.0002
411 PRE-EXISTING CONDITION IMPROVED 1 0.0002
412 THERAPEUTIC RESPONSE CHANGED 1 0.0002
413 FOREIGN BODY SENSATION IN EYES 1 0.0002
414 ROTATOR CUFF SYNDROME 2 0.0002
415 POOR QUALITY DRUG ADMINISTERED 1 0.0002
416 APPLICATION SITE VESICLES 1 0.0002
417 HERPES SIMPLEX 1 0.0002
418 ANGINA UNSTABLE 1 0.0002
419 TENDON DISORDER 1 0.0002
420 POLYP 1 0.0002
421 SOMNAMBULISM 1 0.0002
422 IMMUNE SYSTEM DISORDER 2 0.0002
423 SINUS DISORDER 3 0.0002
424 SKIN DISORDER 5 0.0001
425 QUALITY OF LIFE DECREASED 2 0.0001
426 BREAST MASS 1 0.0001
427 EMOTIONAL DISTRESS 18 0.0001
428 POSTOPERATIVE WOUND INFECTION 1 0.0001
429 ULCER HAEMORRHAGE 1 0.0001
430 IMPAIRED GASTRIC EMPTYING 2 0.0001
431 BLOOD TESTOSTERONE DECREASED 1 0.0001
432 INFARCTION 1 0.0001
433 PRODUCT PREPARATION ERROR 3 0.0001
434 ONYCHOCLASIS 1 0.0001
435 PRODUCT USE IN UNAPPROVED INDICATION 36 0.0001
436 RESPIRATION ABNORMAL 1 0.0001
437 DROOLING 1 0.0001
438 HAIR GROWTH ABNORMAL 1 0.0001
439 DERMATITIS 3 0.0001
440 RIGHT VENTRICULAR FAILURE 1 0.0001
441 SKIN EXFOLIATION 12 0.0001
442 LYMPHADENOPATHY 5 0.0001
443 EATING DISORDER 3 0.0001
444 DRY EYE 7 0.0001
445 PRODUCT SUPPLY ISSUE 1 0.0001
446 POOR QUALITY SLEEP 3 0.0001
447 GRAFT VERSUS HOST DISEASE 1 0.0001
448 VISUAL FIELD DEFECT 1 0.0001
449 DERMATITIS BULLOUS 1 0.0001
450 PRODUCT DISPENSING ERROR 3 0.0001
451 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
452 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
453 ARTHROPOD BITE 1 0.0001
454 GENERAL SYMPTOM 1 0.0001
455 PEMPHIGOID 1 0.0001
456 TENDON PAIN 1 0.0001
457 COLITIS 5 0.0001
458 SKIN IRRITATION 6 0.0001
459 NEPHROLITHIASIS 6 0.0001
460 BOWEL MOVEMENT IRREGULARITY 1 0.0001
461 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
462 HAEMOLYSIS 1 0.0001
463 TENDONITIS 2 0.0001
464 APHTHOUS ULCER 1 0.0001
465 APNOEA 1 0.0001
466 GASTROINTESTINAL INFLAMMATION 1 0.0001
467 BRAIN FOG 2 0.0001
468 MULTIPLE ALLERGIES 1 0.0001
469 CYANOSIS 2 0.0001
470 PRODUCT USE COMPLAINT 2 0.0001
471 SKIN BURNING SENSATION 9 0.0001
472 RASH ERYTHEMATOUS 6 0.0001
473 SCIATICA 2 0.0001
474 UTERINE CANCER 1 0.0001
475 SWELLING FACE 8 0.0001
476 POLYURIA 1 0.0001
477 HYPERAESTHESIA 1 0.0001
478 SPINAL COMPRESSION FRACTURE 1 0.0001
479 DRY SKIN 16 0.0001
480 CELLULITIS 6 0.0001
481 HEMIPARESIS 2 0.0001
482 FACIAL PARALYSIS 1 0.0001
483 VITAMIN D DECREASED 1 0.0001
484 PRODUCT CONTAINER ISSUE 1 0.0001
485 GASTRIC DISORDER 4 0.0001
486 MUSCULOSKELETAL DISCOMFORT 2 0.0001
487 PSYCHOLOGICAL TRAUMA 1 0.0001
488 EXPOSURE VIA SKIN CONTACT 3 0.0001
489 SKIN SWELLING 1 0.0001
490 DISCOMFORT 7 0.0001
491 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
492 BURNING SENSATION 8 0.0001
493 GRIP STRENGTH DECREASED 1 0.0001
494 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
495 RESPIRATORY RATE INCREASED 1 0.0001
496 FACIAL PAIN 1 0.0001
497 THERAPY INTERRUPTED 8 0.0001
498 THIRST 2 0.0001
499 MYOSITIS 1 0.0001
500 THROAT TIGHTNESS 3 0.0001
501 OSTEOMYELITIS 2 0.0001
502 LUPUS-LIKE SYNDROME 1 0.0001
503 MOOD ALTERED 3 0.0001
504 EXOSTOSIS 1 0.0001
505 INCREASED TENDENCY TO BRUISE 1 0.0001
506 OVARIAN CANCER 1 0.0001
507 UROSEPSIS 1 0.0001
508 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
509 MENTAL STATUS CHANGES 3 0.0001
510 HEPATIC STEATOSIS 2 0.0001
511 APPENDICITIS 1 0.0001
512 FLANK PAIN 1 0.0001
513 LACERATION 1 0.0001
514 ABORTION INDUCED 1 0.0001
515 ANXIETY 30 0.0001
516 PRODUCT PACKAGING ISSUE 1 0.0001
517 PULMONARY EMBOLISM 10 0.0001
518 RECALLED PRODUCT ADMINISTERED 1 0.0001
519 EYE INFLAMMATION 1 0.0001
520 SLEEP APNOEA SYNDROME 2 0.0001
521 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
522 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
523 ACUTE RESPIRATORY FAILURE 2 0.0001
524 AUTOIMMUNE DISORDER 1 0.0001
525 CHOKING 2 0.0001
526 PHARYNGEAL SWELLING 1 0.0001
527 INFLAMMATORY BOWEL DISEASE 1 0.0001
528 CONDITION AGGRAVATED 31 0.0001
529 COELIAC DISEASE 1 0.0001
530 KNEE OPERATION 1 0.0001
531 DISABILITY 2 0.0001
532 EMBEDDED DEVICE 1 0.0001
533 SALIVARY HYPERSECRETION 1 0.0001
534 BLOOD POTASSIUM DECREASED 3 0.0001
535 BRAIN INJURY 1 0.0001
536 INJURY 7 0.0001
537 DRUG LEVEL DECREASED 1 0.0001
538 NEUTROPHIL COUNT INCREASED 1 0.0001
539 OSTEOPOROSIS 4 0.0001
540 LIMB DISCOMFORT 3 0.0001
541 ALOPECIA 19 0.0001
542 HYPERBILIRUBINAEMIA 1 0.0001
543 PULMONARY HYPERTENSION 2 0.0001
544 UNINTENDED PREGNANCY 1 0.0001
545 ROAD TRAFFIC ACCIDENT 4 0.0001
546 PRODUCT ODOUR ABNORMAL 1 0.0001
547 INJECTION SITE DISCOMFORT 1 0.0001
548 DERMATITIS ATOPIC 5 0.0001
549 FULL BLOOD COUNT ABNORMAL 1 0.0001
550 BREAST PAIN 1 0.0001
551 PRURITUS 36 0.0001
552 BODY HEIGHT DECREASED 1 0.0001
553 IRRITABLE BOWEL SYNDROME 2 0.0001
554 BREAST CANCER METASTATIC 1 0.0001
555 OEDEMA 5 0.0001
556 BIPOLAR DISORDER 1 0.0001
557 IMPAIRED HEALING 3 0.0001
558 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
559 EYE DISORDER 3 0.0001
560 GASTROINTESTINAL PAIN 1 0.0001
561 MELAENA 2 0.0001
562 TOOTH FRACTURE 1 0.0001
563 FUNGAL INFECTION 3 0.0001
564 HYPERTENSIVE CRISIS 1 0.0001
565 SNEEZING 2 0.0001
566 OCULAR DISCOMFORT 1 0.0001
567 FISTULA 1 0.0001
568 CHROMATURIA 2 0.0001
569 HEART RATE IRREGULAR 2 0.0001
570 MITRAL VALVE INCOMPETENCE 1 0.0001
571 SINUSITIS 9 0.0001
572 SCAB 1 0.0001
573 INTERNAL HAEMORRHAGE 1 0.0001
574 ILLNESS 9 0.0001
575 HERPES ZOSTER 5 0.0001
576 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
577 MUSCLE TWITCHING 2 0.0001
578 OROPHARYNGEAL PAIN 8 0.0001
579 POST PROCEDURAL HAEMORRHAGE 1 0.0001
580 BLOOD CHOLESTEROL INCREASED 4 0.0001
581 SEXUAL DYSFUNCTION 1 0.0001
582 HYPOXIA 3 0.0001
583 NASAL CONGESTION 5 0.0001
584 BLOOD IRON DECREASED 1 0.0001
585 ATAXIA 1 0.0001
586 BACTERAEMIA 1 0.0001
587 PRODUCT PRESCRIBING ERROR 2 0.0001
588 MIGRAINE 8 0.0001
589 MUSCLE RIGIDITY 1 0.0001
590 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
591 CONTUSION 8 0.0001
592 RENAL FAILURE 11 0.0001
593 LOCALISED INFECTION 2 0.0001
594 BURSITIS 1 0.0001
595 PLEURAL EFFUSION 5 0.0001
596 SPINAL OPERATION 1 0.0001
597 TENDON RUPTURE 1 0.0001
598 ABASIA 2 0.0001
599 GENERALISED OEDEMA 1 0.0001
600 PHARYNGITIS 1 0.0001
601 CYST 1 0.0001
602 ILEUS 1 0.0001
603 APPLICATION SITE IRRITATION 1 0.0001
604 HAIR COLOUR CHANGES 1 0.0001
605 DYSPNOEA EXERTIONAL 3 0.0001
606 DERMATITIS ALLERGIC 1 0.0001
607 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
608 BRAIN OEDEMA 1 0.0001
609 DEVICE DEPLOYMENT ISSUE 1 0.0001
610 HEPATITIS 2 0.0001
611 CONSTIPATION 17 0.0001
612 INFUSION SITE PAIN 1 0.0001
613 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
614 INFLAMMATION 4 0.0001
615 HIATUS HERNIA 1 0.0001
616 INJECTION SITE INDURATION 1 0.0001
617 RESPIRATORY TRACT INFECTION 2 0.0001
618 PLATELET COUNT INCREASED 1 0.0001
619 NODULE 1 0.0001
620 SEDATION 2 0.0001
621 MUSCLE SPASMS 14 0.0001
622 ARTHRITIS 6 0.0001
623 JOINT STIFFNESS 2 0.0001
624 ADVERSE REACTION 1 0.0001
625 INSOMNIA 20 0.0001
626 SWELLING 7 0.0001
627 INJECTION SITE PRURITUS 5 0.0001
628 JOINT RANGE OF MOTION DECREASED 1 0.0001
629 PAIN OF SKIN 2 0.0001
630 LIMB INJURY 2 0.0001
631 TACHYPNOEA 1 0.0001
632 PNEUMONITIS 2 0.0001
633 GINGIVAL BLEEDING 1 0.0001
634 ERYTHEMA 15 0.0001
635 CORONARY ARTERY OCCLUSION 1 0.0001
636 SKIN LESION 2 0.0001
637 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
638 MEMORY IMPAIRMENT 10 0.0001
639 HAEMATOCHEZIA 4 0.0001
640 ARTHROPATHY 4 0.0001
641 POLLAKIURIA 3 0.0001
642 NECK PAIN 4 0.0001
643 MASS 1 0.0001
644 BLOOD TEST ABNORMAL 1 0.0001
645 RENAL FAILURE ACUTE 3 0.0001
646 SEASONAL ALLERGY 1 0.0001
647 DIALYSIS 1 0.0001
648 RHEUMATOID ARTHRITIS 8 0.0001
649 INTENTIONAL DOSE OMISSION 2 0.0001
650 EYE IRRITATION 4 0.0001
651 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
652 INJECTION SITE HAEMATOMA 1 0.0001
653 BACK PAIN 16 0.0001
654 LIVER FUNCTION TEST ABNORMAL 2 0.0001
655 NEEDLE ISSUE 2 0.0001
656 GASTROENTERITIS 1 0.0001
657 CHEST DISCOMFORT 7 0.0001
658 LABORATORY TEST ABNORMAL 2 0.0001
659 LIVER DISORDER 3 0.0001
660 SKIN HAEMORRHAGE 1 0.0001
661 ARTHRALGIA 28 0.0001
662 CATARACT 4 0.0001
663 PULMONARY MASS 1 0.0001
664 ABDOMINAL DISTENSION 7 0.0001
665 PAIN 41 0.0001
666 HOT FLUSH 5 0.0001
667 HYPOAESTHESIA ORAL 1 0.0001
668 LACRIMATION INCREASED 2 0.0001
669 STOMATITIS 4 0.0001
670 VERTIGO 4 0.0001
671 DRUG DISPENSING ERROR 1 0.0001
672 BLOOD PRESSURE INCREASED 10 0.0001
673 INSURANCE ISSUE 1 0.0001
674 TINNITUS 3 0.0001
675 HIP ARTHROPLASTY 1 0.0001
676 EMOTIONAL DISORDER 2 0.0001
677 CHEST PAIN 12 0.0001
678 MYALGIA 11 0.0001
679 ANKLE FRACTURE 1 0.0001
680 FEMUR FRACTURE 2 0.0001
681 PAIN IN EXTREMITY 19 0.0001
682 RENAL DISORDER 3 0.0001
683 LUNG INFECTION 1 0.0001
684 COGNITIVE DISORDER 3 0.0001
685 RASH 28 0.0001
686 BASAL CELL CARCINOMA 1 0.0001
687 HEAD INJURY 2 0.0001
688 NEUROPATHY PERIPHERAL 6 0.0001
689 RESPIRATORY TRACT CONGESTION 1 0.0001
690 CYSTITIS 2 0.0001
691 ABSCESS 1 0.0001
692 INJECTION SITE BRUISING 5 0.0001
693 HIP FRACTURE 2 0.0001
694 NIGHT SWEATS 2 0.0001
695 MUSCLE TIGHTNESS 1 0.0001
696 BLOOD CREATININE INCREASED 4 0.0001
697 MANIA 1 0.0001
698 PHOTOSENSITIVITY REACTION 1 0.0001
699 LIP SWELLING 2 0.0001
700 BLOOD UREA INCREASED 1 0.0001
701 ANGER 2 0.0001
702 FATIGUE 46 0.0001
703 FLUID RETENTION 3 0.0001
704 THERAPY CESSATION 3 0.0001
705 PERIPHERAL SWELLING 9 0.0001
706 SCAR 1 0.0001
707 HAEMATURIA 2 0.0001
708 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
709 WEIGHT INCREASED 13 0.0001
710 NIGHTMARE 2 0.0001
711 DEVICE DEFECTIVE 1 0.0001
712 ORTHOSTATIC HYPOTENSION 1 0.0001
713 NERVOUSNESS 3 0.0001
714 MUSCULOSKELETAL PAIN 3 0.0001
715 RASH MACULAR 2 0.0001
716 DEVICE USE ISSUE 1 0.0001
717 SYRINGE ISSUE 1 0.0001
718 MUSCULOSKELETAL STIFFNESS 5 0.0001
719 EOSINOPHILIA 1 0.0001
720 AMENORRHOEA 1 0.0001
721 METASTASES TO LIVER 1 0.0001
722 LYMPHOCYTE COUNT DECREASED 1 0.0001
723 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
724 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
725 ISCHAEMIC STROKE 1 0.0001
726 GOUT 1 0.0001
727 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
728 HYPERGLYCAEMIA 2 0.0001
729 AGITATION 4 0.0001
730 NASOPHARYNGITIS 10 0.0001
731 INFLUENZA 6 0.0001
732 URTICARIA 9 0.0001
733 BLISTER 3 0.0001
734 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
735 HEPATIC CIRRHOSIS 1 0.0001
736 PHOTOPHOBIA 1 0.0001
737 BLOOD SODIUM DECREASED 1 0.0001
738 FRACTURE 1 0.0001
739 BLOOD URINE PRESENT 1 0.0001
740 GASTRIC ULCER 1 0.0001
741 PROTEINURIA 1 0.0001
742 DIABETES MELLITUS 4 0.0001
743 INCREASED APPETITE 1 0.0001
744 ACUTE KIDNEY INJURY 8 0.0001
745 PULMONARY FIBROSIS 1 0.0001
746 POST PROCEDURAL COMPLICATION 1 0.0001
747 LOWER LIMB FRACTURE 1 0.0001
748 HERNIA 1 0.0001
749 PRESCRIBED OVERDOSE 1 0.0001
750 ABDOMINAL PAIN 12 0.0001
751 DYSTONIA 1 0.0001
752 EAR PAIN 1 0.0001
753 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
754 SURGERY 3 0.0001
755 SKIN FISSURES 1 0.0001
756 MENORRHAGIA 1 0.0001
757 DYSPEPSIA 5 0.0001
758 DISORIENTATION 2 0.0001
759 BLOOD PRESSURE ABNORMAL 1 0.0001
760 COMPLICATION OF DEVICE INSERTION 1 0.0001
761 PRESCRIBED UNDERDOSE 1 0.0001
762 PREGNANCY 1 0.0000
763 IRRITABILITY 3 0.0000
764 PRODUCT ADMINISTRATION ERROR 1 0.0000
765 SUICIDE ATTEMPT 3 0.0000
766 EXTRA DOSE ADMINISTERED 2 0.0000
767 FEEDING DISORDER 1 0.0000
768 DRY MOUTH 4 0.0000
769 NEUTROPHIL COUNT DECREASED 2 0.0000
770 FEELING HOT 3 0.0000
771 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
772 HAEMOGLOBIN DECREASED 5 0.0000
773 RIB FRACTURE 1 0.0000
774 INFLUENZA LIKE ILLNESS 4 0.0000
775 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
776 TREATMENT FAILURE 4 0.0000
777 TOOTH LOSS 1 0.0000
778 MOUTH ULCERATION 1 0.0000
779 PLATELET COUNT DECREASED 5 0.0000
780 JOINT INJURY 1 0.0000
781 RHINORRHOEA 3 0.0000
782 PRURITUS GENERALISED 1 0.0000
783 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
784 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
785 VAGINAL HAEMORRHAGE 2 0.0000
786 DEVICE DISLOCATION 2 0.0000
787 PRODUCT DOSE OMISSION 3 0.0000
788 PSORIASIS 6 0.0000
789 STEVENS-JOHNSON SYNDROME 1 0.0000
790 TRANSAMINASES INCREASED 1 0.0000
791 TOOTH DISORDER 1 0.0000
792 GLOSSODYNIA 1 0.0000
793 GASTROINTESTINAL DISORDER 4 0.0000
794 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
795 THROAT IRRITATION 2 0.0000
796 THERAPY NON-RESPONDER 2 0.0000
797 PANCREATITIS ACUTE 1 0.0000
798 ASTHMA 5 0.0000
799 DIZZINESS 22 0.0000
800 APPLICATION SITE PRURITUS 1 0.0000
801 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
802 PRODUCT AVAILABILITY ISSUE 1 0.0000
803 ABDOMINAL PAIN UPPER 9 0.0000
804 SUICIDAL IDEATION 4 0.0000
805 INJECTION SITE REACTION 3 0.0000
806 SHOCK 1 0.0000
807 ADVERSE EVENT 4 0.0000
808 DIARRHOEA 28 0.0000
809 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
810 COUGH 12 0.0000
811 ASTHENIA 16 0.0000
812 HYPERTENSION 9 0.0000
813 DISEASE PROGRESSION 5 0.0000
814 OCULAR HYPERAEMIA 2 0.0000
815 ANAEMIA 8 0.0000
816 PRODUCTIVE COUGH 2 0.0000
817 ABDOMINAL DISCOMFORT 7 0.0000
818 BLOOD PRESSURE FLUCTUATION 1 0.0000
819 DIABETIC KETOACIDOSIS 1 0.0000
820 LUNG DISORDER 2 0.0000
821 PRODUCT DOSE OMISSION ISSUE 12 0.0000
822 LIVER INJURY 1 0.0000
823 BRONCHITIS 3 0.0000
824 PYREXIA 14 0.0000
825 OSTEONECROSIS OF JAW 1 0.0000
826 DYSGEUSIA 3 0.0000
827 VISUAL IMPAIRMENT 5 0.0000
828 INJECTION SITE ERYTHEMA 5 0.0000
829 EPISTAXIS 3 0.0000
830 AGEUSIA 1 0.0000
831 SYNCOPE 4 0.0000
832 COVID-19 7 0.0000
833 DEPRESSION 9 0.0000
834 ABDOMINAL PAIN LOWER 1 0.0000
835 WEIGHT DECREASED 11 0.0000
836 INJECTION SITE SWELLING 3 0.0000
837 ERECTILE DYSFUNCTION 1 0.0000
838 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
839 ANAPHYLACTIC SHOCK 1 0.0000
840 SKIN ULCER 1 0.0000
841 HAEMORRHAGE 4 0.0000
842 SPEECH DISORDER 2 0.0000
843 GASTRITIS 1 0.0000
844 HYPERSENSITIVITY 7 0.0000
845 OFF LABEL USE 33 0.0000
846 EAR INFECTION 1 0.0000
847 THROMBOSIS 3 0.0000
848 JAUNDICE 1 0.0000
849 FREQUENT BOWEL MOVEMENTS 1 0.0000
850 RASH PRURITIC 2 0.0000
851 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
852 PRODUCT QUALITY ISSUE 5 0.0000
853 GAIT DISTURBANCE 7 0.0000
854 RESPIRATORY DISTRESS 1 0.0000
855 SEPSIS 4 0.0000
856 INJECTION SITE PAIN 11 0.0000
857 HAEMOPTYSIS 1 0.0000
858 RENAL IMPAIRMENT 3 0.0000
859 OXYGEN SATURATION DECREASED 2 0.0000
860 RED BLOOD CELL COUNT DECREASED 1 0.0000
861 ANGINA PECTORIS 1 0.0000
862 HYPERSOMNIA 1 0.0000
863 BALANCE DISORDER 3 0.0000
864 INFECTION 5 0.0000
865 INTENTIONAL PRODUCT MISUSE 3 0.0000
866 PALPITATIONS 4 0.0000
867 NAUSEA 27 0.0000
868 VOMITING 16 0.0000
869 ASCITES 1 0.0000
870 ACUTE MYOCARDIAL INFARCTION 1 0.0000
871 PSYCHOTIC DISORDER 1 0.0000
872 URINARY INCONTINENCE 1 0.0000
873 DYSPNOEA 19 0.0000
874 HEADACHE 21 0.0000
875 DEVICE ISSUE 3 0.0000
876 RESPIRATORY DISORDER 1 0.0000
877 JOINT SWELLING 4 0.0000
878 FALL 11 0.0000
879 CORONARY ARTERY DISEASE 1 0.0000
880 THERAPEUTIC RESPONSE DECREASED 2 0.0000
881 ILL-DEFINED DISORDER 2 0.0000
882 DRUG INEFFECTIVE 43 0.0000
883 INJECTION SITE RASH 1 0.0000
884 HOSPITALISATION 5 0.0000
885 CARDIAC DISORDER 3 0.0000
886 SWOLLEN TONGUE 1 0.0000
887 MOOD SWINGS 1 0.0000
888 HYPOTHYROIDISM 1 0.0000
889 HYPERHIDROSIS 4 0.0000
890 AMNESIA 2 0.0000
891 OSTEONECROSIS 1 0.0000
892 STAPHYLOCOCCAL INFECTION 1 0.0000
893 HEART RATE INCREASED 3 0.0000
894 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
895 EXPIRED PRODUCT ADMINISTERED 1 0.0000
896 GAIT INABILITY 1 0.0000
897 SOMNOLENCE 6 0.0000
898 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
899 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
900 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
901 HEPATIC ENZYME INCREASED 2 0.0000
902 URINARY TRACT INFECTION 5 0.0000
903 VISION BLURRED 4 0.0000
904 HEART RATE DECREASED 1 0.0000
905 SLEEP DISORDER 2 0.0000
906 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
907 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
908 PRODUCT ADHESION ISSUE 1 0.0000
909 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
910 CEREBRAL HAEMORRHAGE 1 0.0000
911 MOBILITY DECREASED 2 0.0000
912 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
913 DRUG EFFECT INCOMPLETE 1 0.0000
914 PANIC ATTACK 1 0.0000
915 RESTLESSNESS 1 0.0000
916 DYSURIA 1 0.0000
917 INJECTION SITE MASS 1 0.0000
918 HYPOAESTHESIA 4 0.0000
919 DECREASED APPETITE 6 0.0000
920 PARAESTHESIA 4 0.0000
921 INJECTION SITE HAEMORRHAGE 2 0.0000
922 CARDIAC FAILURE CONGESTIVE 2 0.0000
923 DEVICE BREAKAGE 1 0.0000
924 BLINDNESS 1 0.0000
925 LUNG NEOPLASM MALIGNANT 1 0.0000
926 CARDIAC ARREST 2 0.0000
927 DRUG DOSE OMISSION 4 0.0000
928 TREMOR 4 0.0000
929 CARDIO-RESPIRATORY ARREST 1 0.0000
930 RECTAL HAEMORRHAGE 1 0.0000
931 DEVICE LEAKAGE 1 0.0000
932 SEPTIC SHOCK 1 0.0000
933 MYOCARDIAL INFARCTION 4 0.0000
934 PRODUCT STORAGE ERROR 2 0.0000
935 ANGIOEDEMA 1 0.0000
936 PULMONARY OEDEMA 1 0.0000
937 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
938 ADVERSE DRUG REACTION 2 0.0000
939 HYPOKALAEMIA 1 0.0000
940 PRODUCT USE ISSUE 4 0.0000
941 BLOOD GLUCOSE INCREASED 4 0.0000
942 ARRHYTHMIA 1 0.0000
943 DYSPHAGIA 2 0.0000
944 COMA 1 0.0000
945 BLOOD GLUCOSE DECREASED 1 0.0000
946 AGGRESSION 1 0.0000
947 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
948 FLUSHING 2 0.0000
949 PANCREATITIS 1 0.0000
950 DEPRESSED MOOD 1 0.0000
951 BRADYCARDIA 1 0.0000
952 OVERDOSE 4 0.0000
953 PNEUMONIA 6 0.0000
954 ANAPHYLACTIC REACTION 1 0.0000
955 MEDICATION ERROR 1 0.0000
956 THROMBOCYTOPENIA 2 0.0000
957 EYE PAIN 1 0.0000
958 CEREBROVASCULAR ACCIDENT 3 0.0000
959 FLATULENCE 1 0.0000
960 MUSCULAR WEAKNESS 2 0.0000
961 CONVULSION 1 0.0000
962 DYSPHONIA 1 0.0000
963 CHILLS 2 0.0000
964 FEELING ABNORMAL 4 0.0000
965 OEDEMA PERIPHERAL 2 0.0000
966 EXPOSURE DURING PREGNANCY 1 0.0000
967 MALAISE 7 0.0000
968 INTENTIONAL OVERDOSE 1 0.0000
969 DEVICE EXPULSION 1 0.0000
970 DEVICE DIFFICULT TO USE 1 0.0000
971 DEHYDRATION 2 0.0000
972 NEOPLASM MALIGNANT 1 0.0000
973 HYPOTENSION 3 0.0000
974 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
975 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
976 RESPIRATORY FAILURE 1 0.0000
977 UNDERDOSE 1 0.0000
978 UNEVALUABLE EVENT 1 0.0000
979 DRUG INTERACTION 2 0.0000
980 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
981 TACHYCARDIA 1 0.0000
982 BREAST CANCER 1 0.0000
983 ATRIAL FIBRILLATION 1 0.0000
984 INCORRECT DOSE ADMINISTERED 2 0.0000
985 SEIZURE 1 0.0000
986 NEUTROPENIA 1 0.0000
987 CONFUSIONAL STATE 1 0.0000
988 TOXICITY TO VARIOUS AGENTS 1 0.0000
989 NO ADVERSE EVENT 1 0.0000
990 DEATH 1 0.0000